Literature DB >> 24271511

CLCNKB mutations causing mild Bartter syndrome profoundly alter the pH and Ca2+ dependence of ClC-Kb channels.

Olga Andrini1, Mathilde Keck, Sébastien L'Hoste, Rodolfo Briones, Lamisse Mansour-Hendili, Teddy Grand, Francisco V Sepúlveda, Anne Blanchard, Stéphane Lourdel, Rosa Vargas-Poussou, Jacques Teulon.   

Abstract

ClC-Kb, a member of the ClC family of Cl(-) channels/transporters, plays a major role in the absorption of NaCl in the distal nephron. CLCNKB mutations cause Bartter syndrome type 3, a hereditary renal salt-wasting tubulopathy. Here, we investigate the functional consequences of a Val to Met substitution at position 170 (V170M, α helix F), which was detected in eight patients displaying a mild phenotype. Conductance and surface expression were reduced by ~40-50 %. The regulation of channel activity by external H(+) and Ca(2+) is a characteristic property of ClC-Kb. Inhibition by external H(+) was dramatically altered, with pKH shifting from 7.6 to 6.0. Stimulation by external Ca(2+) on the other hand was no longer detectable at pH 7.4, but was still present at acidic pH values. Functionally, these regulatory modifications partly counterbalance the reduced surface expression by rendering V170M hyperactive. Pathogenic Met170 seems to interact with another methionine on α helix H (Met227) since diverse mutations at this site partly removed pH sensitivity alterations of V170M ClC-Kb. Exploring other disease-associated mutations, we found that a Pro to Leu substitution at position 124 (α helix D, Simon et al., Nat Genet 1997, 17:171-178) had functional consequences similar to those of V170M. In conclusion, we report here for the first time that ClC-Kb disease-causing mutations located around the selectivity filter can result in both reduced surface expression and hyperactivity in heterologous expression systems. This interplay must be considered when analyzing the mild phenotype of patients with type 3 Bartter syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24271511     DOI: 10.1007/s00424-013-1401-2

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  31 in total

1.  Functional and structural analysis of ClC-K chloride channels involved in renal disease.

Authors:  S Waldegger; T J Jentsch
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

Review 2.  Structural basis for ion conduction and gating in ClC chloride channels.

Authors:  Raimund Dutzler
Journal:  FEBS Lett       Date:  2004-04-30       Impact factor: 4.124

3.  Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.

Authors:  D B Simon; R S Bindra; T A Mansfield; C Nelson-Williams; E Mendonca; R Stone; S Schurman; A Nayir; H Alpay; A Bakkaloglu; J Rodriguez-Soriano; J M Morales; S A Sanjad; C M Taylor; D Pilz; A Brem; H Trachtman; W Griswold; G A Richard; E John; R P Lifton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

4.  Spectrum of mutations in Gitelman syndrome.

Authors:  Rosa Vargas-Poussou; Karin Dahan; Diana Kahila; Annabelle Venisse; Eva Riveira-Munoz; Huguette Debaix; Bernard Grisart; Franck Bridoux; Robert Unwin; Bruno Moulin; Jean-Philippe Haymann; Marie-Christine Vantyghem; Claire Rigothier; Bertrand Dussol; Michel Godin; Hubert Nivet; Laurence Dubourg; Ivan Tack; Anne-Paule Gimenez-Roqueplo; Pascal Houillier; Anne Blanchard; Olivier Devuyst; Xavier Jeunemaitre
Journal:  J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 10.121

5.  A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes.

Authors:  Israel Zelikovic; Raymonde Szargel; Ali Hawash; Valentina Labay; Ihab Hatib; Nadine Cohen; Farid Nakhoul
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

Review 6.  Structure and function of clc channels.

Authors:  Tsung-Yu Chen
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

7.  Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.

Authors:  Karine Brochard; Olivia Boyer; Anne Blanchard; Chantal Loirat; Patrick Niaudet; Marie-Alice Macher; Georges Deschenes; Albert Bensman; Stéphane Decramer; Pierre Cochat; Denis Morin; Françoise Broux; Mathilde Caillez; Claude Guyot; Robert Novo; Xavier Jeunemaître; Rosa Vargas-Poussou
Journal:  Nephrol Dial Transplant       Date:  2008-12-18       Impact factor: 5.992

8.  Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene.

Authors:  Atsushi Hayama; Tatemitsu Rai; Sei Sasaki; Shinichi Uchida
Journal:  Histochem Cell Biol       Date:  2003-05-22       Impact factor: 4.304

9.  Barttin increases surface expression and changes current properties of ClC-K channels.

Authors:  Siegfried Waldegger; Nikola Jeck; Petra Barth; Melanie Peters; Helga Vitzthum; Konrad Wolf; Armin Kurtz; Martin Konrad; Hannsjörg W Seyberth
Journal:  Pflugers Arch       Date:  2002-04-09       Impact factor: 3.657

Review 10.  Myotonia caused by mutations in the muscle chloride channel gene CLCN1.

Authors:  Michael Pusch
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

View more
  5 in total

1.  Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome.

Authors:  Chih-Jen Cheng; Yi-Fen Lo; Jen-Chi Chen; Chou-Long Huang; Shih-Hua Lin
Journal:  J Physiol       Date:  2017-06-27       Impact factor: 5.182

2.  Clinical and Genetic Spectrum of Bartter Syndrome Type 3.

Authors:  Elsa Seys; Olga Andrini; Mathilde Keck; Lamisse Mansour-Hendili; Pierre-Yves Courand; Christophe Simian; Georges Deschenes; Theresa Kwon; Aurélia Bertholet-Thomas; Guillaume Bobrie; Jean Sébastien Borde; Guylhène Bourdat-Michel; Stéphane Decramer; Mathilde Cailliez; Pauline Krug; Paul Cozette; Jean Daniel Delbet; Laurence Dubourg; Dominique Chaveau; Marc Fila; Noémie Jourde-Chiche; Bertrand Knebelmann; Marie-Pierre Lavocat; Sandrine Lemoine; Djamal Djeddi; Brigitte Llanas; Ferielle Louillet; Elodie Merieau; Maria Mileva; Luisa Mota-Vieira; Christiane Mousson; François Nobili; Robert Novo; Gwenaëlle Roussey-Kesler; Isabelle Vrillon; Stephen B Walsh; Jacques Teulon; Anne Blanchard; Rosa Vargas-Poussou
Journal:  J Am Soc Nephrol       Date:  2017-04-05       Impact factor: 10.121

3.  Carboxyl-terminal Truncations of ClC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking.

Authors:  Gabriel Stölting; Stefanie Bungert-Plümke; Arne Franzen; Christoph Fahlke
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

4.  In silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening.

Authors:  Maxime Louet; Sara Bitam; Naziha Bakouh; Yohan Bignon; Gabrielle Planelles; David Lagorce; Maria A Miteva; Dominique Eladari; Jacques Teulon; Bruno O Villoutreix
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

5.  Dual regulation of the native ClC-K2 chloride channel in the distal nephron by voltage and pH.

Authors:  Laurent Pinelli; Antoine Nissant; Aurélie Edwards; Stéphane Lourdel; Jacques Teulon; Marc Paulais
Journal:  J Gen Physiol       Date:  2016-09       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.